[1]
R. Khattak, R. Ahmad, M. Nadeem, H. Amjad, A. Khan, and I. ., “QTC Changes Associated with Tyrosine Kinase Inhibitors in Cancer Patients”, Pak Armed Forces Med J, vol. 72, no. 4, pp. 1470–73, Sep. 2022, doi: 10.51253/pafmj.v72i4.6776.